Abstract:Mexican Americans are disproportionally affected by metabolic dysfunction-associated steatotic liver disease (MASLD), which often co-occurs with diabetes. Despite extensive evidence on the causative role of the gut microbiome in MASLD, studies determining the involvement of the gut phageome are scarce. In this cross-sectional study, we characterized the gut phageome in Mexican Americans of South Texas by stool shotgun metagenomic sequencing of 340 subjects, concurrently screened for liver steatosis by transient elastography. Inter-individual variations in the phageome were associated with gender, country of birth, diabetes, and liver steatosis. The phage signatures for diabetes and liver steatosis were subsequently determined. Enrichment of Inoviridae was associated with both diabetes and liver steatosis. Diabetes was further associated with the enrichment of predominantly temperate Escherichia phages, some of which possessed virulence factors. Liver steatosis was associated with the depletion of Lactococcus phages r1t and BK5-T, and enrichment of the globally prevalent Crassvirales phages, including members of genus cluster IX (Burzaovirus coli, Burzaovirus faecalis) and VI (Kahnovirus oralis). The Lactococcus phages showed strong correlations and co-occurrence with Lactococcus lactis, while the Crassvirales phages, B. coli, B. faecalis, and UAG-readthrough crAss clade correlated and co-occurred with Prevotella copri. In conclusion, we identified the gut phageome signatures for two closely linked metabolic diseases with significant global burden. These phage signatures may have utility in risk modeling and disease prevention in this high-risk population, and identification of potential bacterial targets for phage therapy.IMPORTANCEPhages influence human health and disease by shaping the gut bacterial community. Using stool samples from a high-risk Mexican American population, we provide insights into the gut phageome changes associated with diabetes and liver steatosis, two closely linked metabolic diseases with significant global burden. Common to both diseases was an enrichment of Inoviridae, a group of phages that infect bacterial hosts chronically without lysis, allowing them to significantly influence bacterial growth, virulence, motility, biofilm formation, and horizontal gene transfer. Diabetes was additionally associated with the enrichment of Escherichia coli-infecting phages, some of which contained virulence factors. Liver steatosis was additionally associated with the depletion of Lactococcus lactis-infecting phages, and enrichment of Crassvirales phages, a group of virulent phages with high global prevalence and persistence across generations. These phageome signatures may have utility in risk modeling, as well as identify potential bacterial targets for phage therapy.

The Two-Faced Role of crAssphage Subfamilies in Obesity and Metabolic Syndrome: Between Good and Evil

A loss of crAssphage stability in the human gut virome is associated with obesity and metabolic syndrome

Gut Phageome Analysis Reveals Disease-Specific Hallmarks in Childhood Obesity

Gut dsDNA virome shows diversity and richness alterations associated with childhood obesity and metabolic syndrome

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome

Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage

Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes

Alterations in the Gut Virome in Obesity and Type 2 Diabetes Mellitus

Interplay between Intestinal Bacterial Communities and Unicellular Parasites in a Morbidly Obese Population: A Neglected Trinomial

Metagenomic analysis reveals ecological and functional signatures of oral phageome associated with severe early childhood caries

CrAss-Like Phages: From Discovery in Human Fecal Metagenome to Application as a Microbial Source Tracking Marker

Gut microbiome diversity within Clostridia is negatively associated with human obesity

Short Communication: Obesity Intervention Resulting in Significant Changes in the Human Gut Viral Composition

The role of the gut microbiota on the metabolic status of obese children

Characterization Of The Salivary Microbiome In People With Obesity

Dysbiosis and interactions of the salivary bacteriome in obese individuals: A human cross-sectional study

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets

Characterization of the oral and gut microbiome in children with obesity aged 3 to 5 years

Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy